Gh Research Plc Stock Price To Sales
GHRS Stock | USD 9.27 0.35 3.64% |
GH Research PLC fundamentals help investors to digest information that contributes to GH Research's financial success or failures. It also enables traders to predict the movement of GHRS Stock. The fundamental analysis module provides a way to measure GH Research's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GH Research stock.
Last Reported | Projected for Next Year |
GHRS | Price To Sales |
GH Research PLC Company Price To Sales Analysis
GH Research's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
GHRS Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for GH Research is extremely important. It helps to project a fair market value of GHRS Stock properly, considering its historical fundamentals such as Price To Sales. Since GH Research's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GH Research's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GH Research's interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Based on the latest financial disclosure, GH Research PLC has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
GHRS Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GH Research's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GH Research could also be used in its relative valuation, which is a method of valuing GH Research by comparing valuation metrics of similar companies.GH Research is currently under evaluation in price to sales category among its peers.
GH Research ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GH Research's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GH Research's managers, analysts, and investors.Environmental | Governance | Social |
GHRS Fundamentals
Return On Equity | -0.16 | ||||
Return On Asset | -0.13 | ||||
Current Valuation | 333 M | ||||
Shares Outstanding | 52.03 M | ||||
Shares Owned By Insiders | 40.38 % | ||||
Shares Owned By Institutions | 59.15 % | ||||
Number Of Shares Shorted | 1.91 M | ||||
Price To Book | 2.55 X | ||||
EBITDA | (41.15 M) | ||||
Net Income | (35.59 M) | ||||
Cash And Equivalents | 265.38 M | ||||
Cash Per Share | 5.10 X | ||||
Total Debt | 974 K | ||||
Current Ratio | 86.02 X | ||||
Book Value Per Share | 4.21 X | ||||
Cash Flow From Operations | (33.34 M) | ||||
Short Ratio | 30.57 X | ||||
Earnings Per Share | (0.79) X | ||||
Target Price | 31.25 | ||||
Number Of Employees | 49 | ||||
Beta | 0.74 | ||||
Market Capitalization | 482.3 M | ||||
Total Asset | 226.3 M | ||||
Retained Earnings | (67.94 M) | ||||
Working Capital | 157.39 M | ||||
Net Asset | 226.3 M |
About GH Research Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GH Research PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GH Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GH Research PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GHRS Stock Analysis
When running GH Research's price analysis, check to measure GH Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GH Research is operating at the current time. Most of GH Research's value examination focuses on studying past and present price action to predict the probability of GH Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GH Research's price. Additionally, you may evaluate how the addition of GH Research to your portfolios can decrease your overall portfolio volatility.